β„™π•—π•šπ•«π•–π•£ π”Ήπ•šπ• β„•π•‹π•–π•”π•™, π•—π•šπ•£π•€π•₯ π”Ύπ•–π•£π•žπ•’π•Ÿ π•π•’π•¨π•€π•¦π•šπ•₯ 𝕠𝕧𝕖𝕣 π•’π•π•π•–π•˜π•–π•• ℂ𝕆𝕍𝕀𝔻 π•§π•’π•”π•”π•šπ•Ÿπ•– π•€π•šπ••π•– 𝕖𝕗𝕗𝕖𝕔π•₯𝕀.

BioNTech to court Postponed for a few days Lawsuit from a German woman, seeking damages for alleged side effects COVID-19 vaccine

(first of potentially hundreds of cases)

Damages for bodily harm and material damage Claims She suffered vaccine induced upper-body pain, swollen extremities, fatigue and sleeping disorder. Tobias Ulbrich to challenge in court EU and German assessment that the BioNTech has a positive risk-benefit profile.

German criteria Makers of drugs or vaccines, only liable if “medical science” shows that their products cause disproportionate harm, or if the label information is wrong. Comirnaty Given to 1.5 billion (64 million in Germany) The European Medicines Agency (EMA) Has registered almost 1.7 million spontaneous reports of suspected side-effects by May